![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 471/04 | (2006.01) |
A61K 31/437 | (2006.01) | ||
A61K 31/4545 | (2006.01) | ||
A61K 31/444 | (2006.01) | ||
A61K 31/496 | (2006.01) | ||
A61K 31/5377 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 31/10 | (2006.01) | ||
A61P 31/12 | (2006.01) | ||
A61P 19/00 | (2006.01) | ||
A61P 25/28 | (2006.01) |
(11) | Number of the document | 2760285 |
(13) | Kind of document | T |
(96) | European patent application number | 13772420.9 |
Date of filing the European patent application | 2013-03-13 | |
(97) | Date of publication of the European application | 2014-08-06 |
(45) | Date of publication and mention of the grant of the patent | 2017-06-21 |
(46) | Date of publication of the claims translation | 2017-10-10 |
(86) | Number | PCT/US2013/031055 |
Date | 2013-03-13 |
(87) | Number | WO 2013/151708 |
Date | 2013-10-10 |
(30) | Number | Date | Country code |
201261620107 P | 2012-04-04 | US |
(72) |
HOOD, John, US
WALLACE, David, Mark, US
KC, Sunil, Kumar, US
|
(73) |
BioSplice Therapeutics, Inc.,
9360 Towne Centre Drive, San Diego, CA 92121,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Wnt signalinio kelio indazoliniai slopikliai ir jų terapinis panaudojimas |
INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF |
Payment date | Validity (years) | Amount | |
2025-03-05 | 13 | 289.00 EUR |
2026-03-13 |